Nevcihan SAHUTOGLU BAL

Dr. Nevcihan SAHUTOGLU BAL

Department of Pain Medicine, Ankara Bilkent City Hospital, Ankara, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2026 in Medicina
Verified
Journal Article
Open access
PDF file
EBEMEL BASAR
EMEL BASAR
NBNevcihan SAHUTOGLU BAL
Nevcihan SAHUTOGLU BAL
GBGülçin Babaoğlu
Gülçin Babaoğlu
HBHatice Babaoglan
Hatice Babaoglan
EAErkan Yavuz Akcaboy
Erkan Yavuz Akcaboy
Background and Objectives: Knee osteoarthritis is a major cause of chronic pain and disability. Because the benefit of intra-articular corticosteroid injection is often limited, this study compared fluoroscopy-guided corticosteroid injection alone with corticosteroid injection combined with pulsed radiofrequency (PRF). Materials and Methods: This retrospective comparative study included 386 consecutive patients with symptomatic knee osteoarthritis treated with fluoroscopy-guided intra-articular corticosteroid injection alone (IAS, n = 190) or combined with PRF (IAS + PRF, n = 196). Pain and function were assessed using the Visual Analog Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at baseline and 1 week, 1, 3, and 6 months. The primary endpoint was the 6-month VAS score. Baseline-adjusted linear mixed-effects models were the primary analyses, with propensity score-matched analyses as sensitivity analyses. Results: Both groups showed significant improvements in pain over time. In the primary baseline-adjusted analyses, adding PRF was associated with greater early- and mid-term pain reduction, including significantly lower VAS scores at the 6-month primary endpoint and higher rates of clinically meaningful pain improvement (≥50% response). However, this adjusted difference was modest (below the minimal clinically important difference) and was no longer statistically significant after propensity score matching (6-month VAS median 5.0 in both groups; p = 0.763), indicating that baseline imbalance contributed to the apparent advantage. Conclusions: In baseline-adjusted analyses, adding PRF to intra-articular corticosteroid injection was associated with more favourable early- and mid-term pain outcomes than corticosteroid injection alone, although the difference was modest and was not confirmed after propensity score matching. Given the retrospective, non-randomized design and baseline imbalance, these findings should be considered hypothesis-generating. Prospective randomized, sham-controlled studies with longer follow-up are needed to clarify the role of PRF as an adjunctive treatment for knee osteoarthritis.
1

31 May 2026 in Turkish Journal of Clinical Research
Verified
Journal Article
Closed access
EBEmel Basar
Emel Basar
NBNevcihan SAHUTOGLU BAL
Nevcihan SAHUTOGLU BAL
Aim: To evaluate the short-term effectiveness and safety of ultrasound-guided proximal C2 greater occipital nerve block in patients with chronic migraine. Methods: This single-center, retrospective observational study included 41 consecutive adults with chronic migraine diagnosed according to the International Classification of Headache Disorders, 3rd edition (ICHD-3), who underwent ultrasound-guided greater occipital nerve block at the proximal C2 level in the Department of Pain Medicine. Pain intensity, monthly headache days, monthly number of days with headache severity > 5, attack duration, and patient-reported outcomes (HIT-6 and GPE) were assessed at baseline and at the 1st week, 1st month, and 3rd month follow-up visits. Changes over time were analyzed using appropriate non-parametric tests for repeated measures. Results: Monthly headache days, monthly number of days with headache severity >5, pain intensity, and attack duration were significantly lower at the 1st and 3rd months than at baseline (all p<0.001). GPE scores did not differ significantly during follow-up (p=0.059). HIT-6 scores were significantly lower at the 1st and 3rd months than at baseline (both p<0.001), with no significant difference between the 1st and 3rd months (p=1.000). When a Likert score of 2 was defined as treatment success, the success rate increased significantly across follow-up visits (Cochran’s Q test, p <0.001), from 7.3% at the 1st week to 36.6% at the 3rd month. No major procedure-related complications were observed. Conclusion: Ultrasound-guided greater occipital nerve block performed at the proximal C2 level appears to be a safe and clinically useful short-term treatment option in patients with chronic migraine. This approach was associated with reductions in headache burden, pain severity, and headache-related disability, with increasing patient-reported treatment success over the 3-month follow-up period.

Verified
Journal Article
Open access
PDF file
GBGülçin Babaoğlu
Gülçin Babaoğlu
AÇAli Çoştu
Ali Çoştu
ÜSÜLKÜ SABUNCU
ÜLKÜ SABUNCU
Sukriye DadaliSukriye Dadali
Sukriye Dadali
NBNevcihan SAHUTOGLU BAL
Nevcihan SAHUTOGLU BAL
EAErkan Yavuz Akçaboy
Erkan Yavuz Akçaboy
Background/Objectives: Peripheral pulsed radiofrequency (PRF) is a minimally invasive option for trigeminal neuralgia (TN) with a favorable safety profile compared with neurorestorative techniques, but its durability and recurrence patterns remain uncertain. This study evaluated the early effectiveness, durability, recurrence-free survival, and safety of peripheral PRF in refractory classical or idiopathic TN. Methods: This retrospective single-center cohort study assessed procedure-level outcomes of peripheral PRF targeting the ophthalmic, maxillary, and mandibular branches. Pain intensity and clinical status were evaluated using the Numeric Rating Scale (NRS) and Barrow Neurological Institute (BNI) pain score. Early effectiveness was defined as clinically meaningful pain relief sustained for at least 1 month, and sustained effectiveness as NRS ≤ 3 at 6 months. Recurrence-free survival was analyzed using Kaplan–Meier methods. Results: A total of 68 procedures in 57 patients were analyzed. Early effectiveness at 1 month was achieved in 85.3% of procedures. Median NRS decreased from 9 (IQR 8–9) at baseline to 2 (0–4) at 1 month and 0 (0–2) at 3 and 6 months (p < 0.001). In a worst-case analysis, 6-month sustained effectiveness was 72.1%. Recurrence occurred in 61.8% of procedures, with a median recurrence-free survival of 11 months. Among procedures with recurrence, repeat peripheral PRF was performed in 45.2%. Medication requirements decreased in 66.2% of procedures, and no major complications occurred. Conclusions: Peripheral PRF provides rapid and meaningful early pain relief in TN, but durability is limited. These findings support peripheral PRF as a safe, repeatable neuromodulatory intervention within a staged treatment strategy rather than a definitive therapy.
1

13 August 2026 in Medicina
Verified
Journal Article
Open access
PDF file
Sukriye DadaliSukriye Dadali
Sukriye Dadali
NBNevcihan SAHUTOGLU BAL
Nevcihan SAHUTOGLU BAL
ÜSÜLKÜ SABUNCU
ÜLKÜ SABUNCU
GBGülçin Babaoğlu
Gülçin Babaoğlu
AÇAli Çoştu
Ali Çoştu
EAErkan Yavuz Akcaboy
Erkan Yavuz Akcaboy
Background and Objectives: Greater occipital nerve pulsed radiofrequency (GON-PRF) is an effective neuromodulatory treatment for migraine; however, evidence directly comparing unilateral and bilateral approaches remains limited. This prospective randomized controlled trial compared the clinical efficacy of ultrasound-guided proximal GON-PRF performed unilaterally versus bilaterally at the C2 level in patients with migraine. Materials and Methods: A total of 187 patients were randomized to receive unilateral (n = 91) or bilateral (n = 96) ultrasound-guided proximal GON-PRF without concomitant local anesthetic or corticosteroids. Per-protocol analyses included 78 and 88 participants in the unilateral and bilateral groups, respectively. The primary outcome was the change in monthly headache days (MHD) from baseline to 6 months. Secondary outcomes included Visual Analog Scale (VAS) scores, acute medication days (AMD), Headache Impact Test-6 (HIT-6) scores, Migraine Disability Assessment (MIDAS) grades, and Global Perceived Effect (GPE) scores. Longitudinal outcomes were analyzed using multivariable Generalized Estimating Equations (GEE). Results: Of the 187 randomized participants, 166 completed the 6-month follow-up and were included in the per-protocol analysis. Both groups demonstrated significant improvements in all outcomes throughout follow-up (all p < 0.001). At month 6, the Bilateral Group showed lower MHD values (median [IQR]: 7.0 [6.0] vs. 10.0 [6.0], p = 0.030), a higher ≥50% MHD responder rate (77.3% vs. 55.1%, p = 0.003), and lower AMD values (p = 0.024). Adjusted GEE analyses demonstrated significant treatment effects favoring the Bilateral Group for average VAS (p = 0.047) and HIT-6 (p = 0.004). GPE scores also favored the Bilateral Group at month 6 (p = 0.044). No procedure-related complications occurred. Conclusions: Both unilateral and bilateral ultrasound-guided proximal GON-PRF provided significant clinical improvement in patients with migraine. However, bilateral treatment demonstrated superior longitudinal outcomes, including lower headache frequency, reduced acute medication use, higher ≥50% MHD responder rates, and greater patient-reported improvement. These findings remained consistent after adjustment for baseline covariates.
1

15 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
NBNevcihan SAHUTOGLU BAL
Nevcihan SAHUTOGLU BAL
Sukriye DadaliSukriye Dadali
Sukriye Dadali
AÇAli Çoştu
Ali Çoştu
GBGülçin Babaoğlu
Gülçin Babaoğlu
ÜSÜLKÜ SABUNCU
ÜLKÜ SABUNCU
EAErkan Yavuz Akçaboy
Erkan Yavuz Akçaboy
Background and Objectives: Pulsed radiofrequency (PRF) of the cervical medial branches is a non-destructive neuromodulatory option for chronic cervical facet joint pain, yet evidence regarding the durability of clinical response and factors associated with sustained benefit remains limited. This study aimed to characterize the 6-month trajectory of pain and disability after fluoroscopy-guided cervical medial branch PRF and to explore baseline factors associated with meaningful pain relief (MPR). Materials and Methods: In this retrospective single-center cohort study, 75 patients with chronic cervical facet joint pain who achieved ≥50% temporary pain relief following a diagnostic medial branch block underwent fluoroscopy-guided cervical medial branch PRF, followed by injection of local anesthetic and corticosteroid at the treated levels. Numeric Rating Scale (NRS) and Neck Disability Index (NDI) scores were evaluated at baseline and at 1, 3, and 6 months. MPR was defined as ≥50% reduction in NRS from baseline. Global Perceived Effect (GPE) and changes in analgesic medication use were assessed as complementary clinical outcomes. An exploratory multivariable logistic regression analysis was performed to examine factors independently associated with MPR at 6 months. Results: Median NRS scores decreased from 7.0 at baseline to 4.0, 4.0, and 5.0 at 1, 3, and 6 months, respectively, while median NDI scores decreased from 30.0 to 14.0, 16.0, and 20.0 (both overall p < 0.001). Despite sustained improvement relative to baseline, MPR progressively declined from 57.3% at 1 month to 49.3% at 3 months and 36.0% at 6 months (overall p < 0.001). Favorable GPE and reduced analgesic medication use showed parallel declines, supporting attenuation of overall clinical benefit over time. In the exploratory multivariable model, fibromyalgia was independently associated with 75% lower odds of 6-month MPR (OR = 0.25, 95% CI: 0.088–0.709; p = 0.009). Age, sex, and baseline NRS were not significantly associated with 6-month MPR. No serious acute periprocedural adverse events were documented during the 2 h observation period. Conclusions: Fluoroscopy-guided cervical medial branch PRF, combined with post-procedural corticosteroid and local anesthetic administration, was associated with clinically meaningful improvements in both pain and neck-related disability, with the greatest benefit during the first 3 months and partial attenuation by 6 months. The progressive decline across pain response, patient-reported global improvement, and analgesic-use outcomes highlights the time-dependent nature of the benefit associated with the combined intervention. Fibromyalgia was independently associated with substantially lower odds of 6-month MPR in this exploratory analysis; this association should be interpreted cautiously and requires prospective validation before it can inform patient selection, although it may be relevant when counseling patients regarding the durability of response.

25 October 2026 in Anatolian Current Medical Journal
Verified
Journal Article
Open access
Sukriye DadaliSukriye Dadali
Sukriye Dadali
MYMustafa Cem YILMAZ
Mustafa Cem YILMAZ
AÇAli Çoştu
Ali Çoştu
ÜSÜLKÜ SABUNCU
ÜLKÜ SABUNCU
GBGülçin Babaoğlu
Gülçin Babaoğlu
EAErkan Yavuz Akçaboy
Erkan Yavuz Akçaboy
Aims: To evaluate clinical outcomes, patient-reported global improvement, and documented adverse events associated with thoracic interlaminar epidural steroid injections in a real-world cohort with chronic thoracic pain, predominantly postherpetic neuralgia (PHN).Methods: This retrospective single-center study included consecutive adults who underwent thoracic interlaminar epidural steroid injection between January 2022 and December 2025. Pain intensity was assessed using the Numeric Rating Scale (NRS) at baseline and at 1 and 6 months. Global Perceived Effect (GPE), ≥30% and ≥50% NRS responder rates, repeat injections, and documented adverse events were evaluated. Limited missing follow-up information was completed by telephone in five patients under the ethics-approved protocol. Changes in NRS were analyzed using the Friedman test with Bonferroni-adjusted Wilcoxon signed-rank comparisons.Results: Forty-one patients were included; PHN was the predominant etiology (24/41, 58.5%). Median NRS decreased from 7.0 (IQR, 1.0; range, 6-9) at baseline to 3.0 (IQR, 4.0; range, 0-8) at 1 month and 1.0 (IQR, 3.5; range, 0-7) at 6 months (overall p